Aiding Adherence to Glaucoma Medications: A Systematic Review

REFERENCES

• Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82:887–888.
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
   PubMed Web of Science ®Google Scholar
• Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385(9975):1295–1304. doi:10.1016/S0140-6736(14)62111-5.
   PubMed Web of Science ®Google Scholar
• Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515–523. doi:10.1016/0002-9394(86)90939-6.
   PubMed Web of Science ®Google Scholar
• Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052–5057. doi:10.1167/iovs.07-0290.
   PubMed Web of Science ®Google Scholar
• Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83(5):711–716. doi:10.2105/AJPH.83.5.711.
   PubMed Web of Science ®Google Scholar
• Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl1):S57–68. doi:10.1016/j.survophthal.2008.08.002.
   PubMed Web of Science ®Google Scholar
• Sayner R, Carpenter DM, Blalock SJ, et al. Accuracy of patient-reported adherence to glaucoma medications on a visual analog scale compared with electronic monitors. Clin Ther. 2015;37(9):1975–1985. doi:10.1016/j.clinthera.2015.06.008.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2020;127(4):477–483. doi:10.1016/j.ophtha.2019.10.022.
   PubMed Web of Science ®Google Scholar
• Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410–414. doi:10.5301/EJO.2010.6112.
   PubMed Web of Science ®Google Scholar
• Beckers HJ, Webers CA, Busch MJ, Brink HM, Colen TP, Schouten JS. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial. Acta Ophthalmol. 2013;91(7):610–618. doi:10.1111/j.1755-3768.2012.02571.x.
   PubMed Web of Science ®Google Scholar
• Blondeau P, Carbonneau M, Esper P, Turcotte PC. A 2-hour information session and patient recall has minimal impact on glaucoma-treatment persistence in a mature practice. J Glaucoma. 2012;21(6):379–382. doi:10.1097/IJG.0b013e3182127a9b.
   PubMed Web of Science ®Google Scholar
• Boland MV, Chang DS, Frazier T, Plyler R, Jefferys JL, Friedman DS. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study. JAMA Ophthalmol. 2014;132(7):845–850. doi:10.1001/jamaophthalmol.2014.857.
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, Fordham R, Notley C, Broadway DC. Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management. BMC Ophthalmol. 2012;12:57. doi:10.1186/1471-2415-12-57.
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Broadway DC. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol. 2014;14:32. doi:10.1186/1471-2415-14-32.
   PubMed Web of Science ®Google Scholar
• Chang JS Jr, Lee DA, Petursson G, et al. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J. Ocul. Pharmacol. 1991;7(2):117–124. doi:10.1089/jop.1991.7.117.
   PubMedGoogle Scholar
• Chen X, Chen Y, Sun X. Notable role of glaucoma club on patients’ knowledge of glaucoma. Clin Exp Ophthalmol. 2009;37(6):590–594. doi:10.1111/j.1442-9071.2009.02101.x.
   PubMed Web of Science ®Google Scholar
• Cook PF, Bremer RW, Ayala AJ, Kahook MY. Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol. 2010;4:1091–1101. doi:10.2147/OPTH.S12765.
   PubMedGoogle Scholar
• Djafari F, Lesk MR, Giguère C, Siam G, Freeman EE. Impact of a brief educational intervention on glaucoma persistence: a randomized controlled clinical trial. Ophthalmic Epidemiol. 2015;22(6):380–386. doi:10.3109/09286586.2015.1083036.
   PubMed Web of Science ®Google Scholar
• Dreer LE, Girkin CA, Campbell L, Wood A, Gao L, Owsley C. Glaucoma medication adherence among African Americans: program development. Optom Vis Sci. 2013;90(8):883–897. doi:10.1097/OPX.0000000000000009.
   PubMed Web of Science ®Google Scholar
• Dreer LE, Owsley C, Campbell L, Gao L, Wood A, Girkin CA. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African americans: “ g laucoma management o ptimism for A frican Americans L iving with glaucoma. Curr Eye Res. 2016;41(1):50–58. doi:10.3109/02713683.2014.1002045.
   PubMed Web of Science ®Google Scholar
• Fiscella R, Caplan E, Kamble P, Bunniran S, Uribe C, Chandwani H. The effect of an educational intervention on adherence to intraocular pressure-lowering medications in a large cohort of older adults with glaucoma. J Manag Care Spec Pharm. 2018;24:1284–1294.
   PubMed Web of Science ®Google Scholar
• Flowers B, Wand M, Piltz-Seymour J, et al. Patients’ and physicians’ perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension. Clin Ther. 2006;28(11):1803–1811. doi:10.1016/j.clinthera.2006.11.001.
   PubMed Web of Science ®Google Scholar
• Glanz K, Beck AD, Bundy L, et al. Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Arch Ophthalmol. 2012;130(10):1252–1258. doi:10.1001/archophthalmol.2012.1607.
   PubMedGoogle Scholar
• Gray TA, Fenerty C, Harper R, et al. Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (Lond). 2012;26(3):407–417. doi:10.1038/eye.2011.269.
   PubMed Web of Science ®Google Scholar
• Gupta VS, Sethi H, Naik M. Strategies to improve glaucoma compliance based on cross-sectional response-based data in a tertiary healthcare center: the glauco-jung study. J Curr Glaucoma Pract. 2015;9(2):38–46. doi:10.5005/jp-journals-10008-1182.
   PubMedGoogle Scholar
• Hermann MM, Bron AM, Creuzot-Garcher CP, Diestelhorst M. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. J Glaucoma. 2011;20(8):502–508. doi:10.1097/IJG.0b013e3181f3eb4a.
   PubMed Web of Science ®Google Scholar
• Killeen OJ, MacKenzie C, Heisler M, Resnicow K, Lee PP, Newman-Casey PA. User-centered design of the eyeguide: a tailored glaucoma behavior change program. J Glaucoma. 2016;25(10):815–821. doi:10.1097/IJG.0000000000000431.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Niziol LM, Mackenzie CK, et al. Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design. Pilot Feasibility Stud. 2018;4:128. doi:10.1186/s40814-018-0320-6.
   PubMedGoogle Scholar
• Hollenhorst CN, Elliott V, Heisler M, Schneider K, Resnicow K, Newman-Casey PA. Patient Experience during the support, educate, empower glaucoma coaching program to improve medication adherence: a pilot study. Ophthalmol Glaucoma. 2020;3(4):238–252. doi:10.1016/j.ogla.2020.04.016.
   PubMedGoogle Scholar
• Newman-Casey PA, Niziol LM, Lee PP, Musch DC, Resnicow K, Heisler M. The impact of the support, educate, empower personalized glaucoma coaching pilot study on glaucoma medication adherence. Ophthalmol Glaucoma. 2020;3(4):228–237. doi:10.1016/j.ogla.2020.04.013.
   PubMedGoogle Scholar
• Lai Y, Wu Y, Chai C, et al. The effect of patient education and telemedicine reminders on adherence to eye drops for glaucoma. Ophthalmol Glaucoma. 2020;3(5):369–376. doi:10.1016/j.ogla.2020.05.005.
   PubMedGoogle Scholar
• Laibovitz R, Boyle J, Snyder E, Strohmaier K, Adamsons I. Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life. Clin Ther. 1996;18(5):821–832. doi:10.1016/S0149-2918(96)80042-7.
   PubMed Web of Science ®Google Scholar
• Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc. 1996;67:654–658.
   PubMedGoogle Scholar
• Leshno A, Gaton D, Singer R, et al. A novel EyePhone© App for improving adherence to glaucoma therapy. Graefes Arch Clin Exp Ophthalmol. 2021;259:1253–1262. doi:10.1007/s00417-021-05091-6.
   PubMed Web of Science ®Google Scholar
• Lim MC, Watnik MR, Imson KR, Porter SM, Granier AM. Adherence to glaucoma medication: the effect of interventions and association with personality type. J Glaucoma. 2013;22(6):439–446. doi:10.1097/IJG.0b013e31824cd0ae.
   PubMed Web of Science ®Google Scholar
• Lunnela J, Kääriäinen M, Kyngäs H. Web-based intervention for improving adherence of people with glaucoma. J Nurs Healthcare Chron Ill. 2011;3(2):119–129. doi:10.1111/j.1752-9824.2011.01097.x.
   Google Scholar
• Mammo DA, Strampe M, Naravane A, Mallory PW, Boysen J, Wright MM. Inpatient adherence to topical glaucoma medications before and after an educational intervention. Ophthalmol Glaucoma. 2020;3(5):339–342. doi:10.1016/j.ogla.2020.04.007.
   PubMedGoogle Scholar
• McVeigh KA, Vakros G. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015;9:813–819.
   PubMed Web of Science ®Google Scholar
• Muir KW, Ventura A, Stinnett SS, Enfiedjian A, Allingham RR, Lee PP. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns. 2012;87(2):160–164. doi:10.1016/j.pec.2011.09.009.
   PubMed Web of Science ®Google Scholar
• Muir KW, Rosdahl JA, Hein AM, et al. Improved glaucoma medication adherence in a randomized controlled trial. Ophthalmology Glaucoma. 2021. doi:10.1016/j.ogla.2021.04.006.
   Google Scholar
• Rosdahl JA, Hein AM, Bosworth HB, et al. Randomized controlled trial of an education-based intervention to improve medication adherence: design considerations in the medication adherence in glaucoma to improve care study. Clin Trials. 2021;18(3):343-350. doi: 10.1177/1740774520988291.
   PubMedGoogle Scholar
• Nakakura S, Tabuchi H, Baba Y, et al. Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial. Clin Ophthalmol. 2012;6:369–375. doi:10.2147/OPTH.S29912.
   PubMedGoogle Scholar
• Norell SE. Improving medication compliance: a randomised clinical trial. Br Med J. 1979;2(6197):1031–1033. doi:10.1136/bmj.2.6197.1031.
   PubMed Web of Science ®Google Scholar
• Granström PA. Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects. Br J Ophthalmol. 1982;66(7):464–470. doi:10.1136/bjo.66.7.464.
   PubMed Web of Science ®Google Scholar
• Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286–2293. doi:10.1016/j.ophtha.2009.05.026.
   PubMed Web of Science ®Google Scholar
• Rendell J. Effect of health education on patients’ beliefs about glaucoma and compliance. Insight. 2000;25:112–118.
   PubMedGoogle Scholar
• Richardson C, Brunton L, Olleveant N, et al. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Prefer Adherence. 2013;7:1025–1039. doi:10.2147/PPA.S47785.
   PubMed Web of Science ®Google Scholar
• Sakai H, Shinjyo S, Nakamura Y, Nakamura Y, Ishikawa S, Sawaguchi S. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients. J Ocul Pharmacol Ther. 2005;21(6):483–489. doi:10.1089/jop.2005.21.483.
   PubMed Web of Science ®Google Scholar
• Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma. Clin Ther. 1999;21(1):138–147. doi:10.1016/S0149-2918(00)88274-0.
   PubMed Web of Science ®Google Scholar
• Sclar DA, Skaer TL, Chin A, Okamoto MP, Nakahiro RK, Gill MA. Effectiveness of the C cap in promoting prescription refill compliance among patients with glaucoma. Clin Ther. 1991;13:396–400.
   PubMed Web of Science ®Google Scholar
• Sheppard J, Warner J, Kelley K. An evaluation of the effectiveness of a nurse-led glaucoma monitoring clinic. Ophthalmic. Nurs. 2003;7(2):15–21.
   Google Scholar
• Sleath B, Blalock SJ, Carpenter DM, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2015;122(4):748–754. doi:10.1016/j.ophtha.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Sleath B, Carpenter DM, Blalock SJ, et al. Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence. Health Educ Res. 2015;30(5):693–705. doi:10.1093/her/cyv034.
   PubMed Web of Science ®Google Scholar
• Sleath BL, Blalock SJ, Muir KW, et al. Determinants of self-reported barriers to glaucoma medicine administration and adherence: a multisite study. Ann Pharmacother. 2014;48(7):856–862. doi:10.1177/1060028014529413.
   PubMed Web of Science ®Google Scholar
• Stack RR, McKellar MJ. Black eye drop bottle tips improve compliance. Clin Exp Ophthalmol. 2004;32(1):39–41. doi:10.1046/j.1442-9071.2004.00705.x.
   PubMed Web of Science ®Google Scholar
• Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. J Glaucoma. 1999;8(5):315–324. doi:10.1097/00061198-199910000-00008.
   PubMed Web of Science ®Google Scholar
• Vin A, Schneider S, Muir KW, Rosdahl JA. Health coaching for glaucoma care: a pilot study using mixed methods. Clin Ophthalmol. 2015;9:1931–1943.
   PubMed Web of Science ®Google Scholar
• Waisbourd M, Dhami H, Zhou C, et al. The wills eye glaucoma app: interest of patients and their caregivers in a smartphone-based and tablet-based glaucoma application. J Glaucoma. 2016;25(9):e787–791. doi:10.1097/IJG.0000000000000504.
   PubMed Web of Science ®Google Scholar
• Kowing D, Messer D, Slagle S, Wasik A. Programs to optimize adherence in glaucoma. Optometry. 2010;81(7):339–350. doi:10.1016/j.optm.2009.09.021.
   PubMedGoogle Scholar
• McDonald JE, Dickinson JK, Novel A. Approach to helping people with glaucoma use their drops routinely. Optom Vis Sci. 2019;96(5):331–334. doi:10.1097/OPX.0000000000001366.
   PubMed Web of Science ®Google Scholar
• Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2009;23(4):924–932. doi:10.1038/eye.2008.103.
   PubMed Web of Science ®Google Scholar
• Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma adherence and persistency study. Ophthalmology. 2008;115(8):1320–1327, 1327.e1321-1323. doi:10.1016/j.ophtha.2007.11.023.
   Web of Science ®Google Scholar
• Sclar DA, Skaer TL, Chin A, Okamoto MP, Nakahiro RK, Gill MA. Effectiveness of the C Cap(TM) in promoting prescription refill compliance among patients with glaucoma. Clin Ther. 1991;13:396–400.
   PubMed Web of Science ®Google Scholar
• Leonard K, Masatu MC. Outpatient process quality evaluation and the Hawthorne effect. Soc Sci Med. 2006;63(9):2330–2340. doi:10.1016/j.socscimed.2006.06.003.
   PubMed Web of Science ®Google Scholar
• Mangione-Smith R, Elliott MN, McDonald L, McGlynn EA. An observational study of antibiotic prescribing behavior and the Hawthorne effect. Health Serv Res. 2002;37(6):1603–1623. doi:10.1111/1475-6773.10482.
   PubMed Web of Science ®Google Scholar
• Varadaraj V, Kahook MY, Ramulu PY, Pitha IF. Patient acceptance of sustained glaucoma treatment strategies. J Glaucoma. 2018;27(4):328–335. doi:10.1097/IJG.0000000000000913.
   PubMed Web of Science ®Google Scholar
• Brandt JD, DuBiner HB, Benza R, Sall KN, Walker GA, Semba CP. Long-term safety and efficacy of a sustained-release bimatoprost ocular ring. Ophthalmology. 2017;124(10):1565–1566. doi:10.1016/j.ophtha.2017.04.022.
   PubMed Web of Science ®Google Scholar
• Lewis RA, Christie WC, Day DG, et al. Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I/II clinical trial. Am J Ophthalmol. 2017;175:137–147. doi:10.1016/j.ajo.2016.11.020.
   PubMed Web of Science ®Google Scholar
• Natarajan JV, Chattopadhyay S, Ang M, et al. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PLoS One. 2011;6(9):e24513. doi:10.1371/journal.pone.0024513.
   PubMed Web of Science ®Google Scholar
• Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009;50(7):3346–3352. doi:10.1167/iovs.08-2826.
   PubMed Web of Science ®Google Scholar
• Patil S, Reshetnikov S, Haldar MK, Seal S, Mallik S. Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: a potential drug delivery device. J Phys Chem C. 2007;111(24):8437–8442. doi:10.1021/jp067666l.
   Web of Science ®Google Scholar